Marshall Wace’s Hims & Hers Health HIMS Stock Holding History

Marshall Wace’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-352,300	Closed	-$8.52M	–	2816
2024 Q4	$8.52M	Buy	+352,300	New	+$8.73M	0.01%	852

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace's HIMS Position: Q2 2026 in Review

Marshall Wace increased its Hims & Hers Health (HIMS) stake by 482% in Q2 2026, buying an estimated $93.8M and bringing the position to 4,217,767 shares worth $146M. The position accounts for 0.12% of the portfolio, ranked #137.

Marshall Wace first reported a position in HIMS in Q4 2019 and has held it in 24 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Marshall Wace held 4,217,767 shares of Hims & Hers Health worth $146M as of Q2 2026.
Marshall Wace bought 3,493,540 Hims & Hers Health shares in Q2 2026, an estimated $93.8M.
Hims & Hers Health made up 0.12% of Marshall Wace's portfolio in Q2 2026, its #137 holding.
Marshall Wace first reported a position in Hims & Hers Health in Q4 2019 and has held it in 24 quarters since.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.